These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 4861314)
1. The clinical evaluation of drugs for leprosy. Browne SG Trans R Soc Trop Med Hyg; 1967; 61(4):601-7. PubMed ID: 4861314 [No Abstract] [Full Text] [Related]
2. Studies on sulfone resistance in leprosy. 3. A case of "partial" resistance. Pearson JM; Pettit JH; Rees RJ Int J Lepr Other Mycobact Dis; 1968; 36(2):171-8. PubMed ID: 4877115 [No Abstract] [Full Text] [Related]
3. Correlation of laboratory and clinical data during treatment of leprosy. Pattyn SR; Rollier R; Rollier MR; De Muynck A; Janssens PG; Verdoolaeghe-Van Loo G Ann Soc Belg Med Trop; 1972; 52(6):537-48. PubMed ID: 4574223 [No Abstract] [Full Text] [Related]
4. Comments on the chemotherapy of leprosy as influenced by present knowledge of Mycobacterium leprae. Pattyn SR Lepr Rev; 1973 Sep; 43(3):126-36. PubMed ID: 4120832 [No Abstract] [Full Text] [Related]
7. Chemotherapeutic trials in leprosy. 5. A study of methods used in clinical trials in lepromatous leprosy. Waters MF; Rees RJ; Sutherland I Int J Lepr Other Mycobact Dis; 1967; 35(3):311-35. PubMed ID: 4917107 [No Abstract] [Full Text] [Related]
11. Increase in prevalence of leprosy caused by dapsone-resistant Mycobacterium leprae. Centers for Disease Control (CDC) MMWR Morb Mortal Wkly Rep; 1982 Jan; 30(52):637-8. PubMed ID: 6798411 [No Abstract] [Full Text] [Related]
12. Six cases of dapsone-resistant tuberculoid leprosy. Pearson JM; Kiran KU; Stanley JN Int J Lepr Other Mycobact Dis; 1984 Dec; 52(4):534-5. PubMed ID: 6399070 [No Abstract] [Full Text] [Related]
13. Survey of primary dapsone-resistant leprosy. Wang HY; Li WZ; Yang LH; Huang HS; Lu WQ; Yu LC Proc Chin Acad Med Sci Peking Union Med Coll; 1986; 1(3):173-5. PubMed ID: 3321049 [No Abstract] [Full Text] [Related]
14. Chemotherapy of leprosy. Shepard CC Annu Rev Pharmacol; 1969; 9():37-50. PubMed ID: 4892433 [No Abstract] [Full Text] [Related]
15. [Prevalence of dapsone-resistant leprosy in Burundi. Temporary results]. Bourland J; Van Loo L; Pattyn SR Acta Leprol; 1982; (86-87):29-33. PubMed ID: 6815995 [No Abstract] [Full Text] [Related]
16. Co-incident (simultaneous) dapsone sensitive and dapsone resistant leprosy. McDougall AC; Ross WF Int J Lepr Other Mycobact Dis; 1982 Jun; 50(2):214-5. PubMed ID: 6749709 [No Abstract] [Full Text] [Related]
17. Lepra reaction. Its relation with fragmentation of Mycobacterium leprae under sulfone therapy. Saul A; Segura N Int J Lepr Other Mycobact Dis; 1966; 34(1):17-22. PubMed ID: 5327411 [No Abstract] [Full Text] [Related]